Announced Tue, 8 Sept · 19:11 IST
Ennature Bio Pharma allots shares to IGL shareholders under demerger scheme
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.2%1-day move
₹287.00
prior close
₹301.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+7.2+2.8-2.4-7.2-12.9-10.8————
Up moveDown movePending
AI summary
Under a scheme of arrangement, Ennature Bio Pharma has allotted 2.23 crore equity shares (face value Rs 5) to India Glycols shareholders in a 1:3 ratio, based on the record date of 2 Sept 2026. EBL also appointed a new CFO Ajay Sharma, Company Secretary Preeti Choudhary, Secretarial Auditor, and Internal Auditor. Shares will rank equally with existing EBL shares and an Information Memorandum was approved for listing and trading approval.
Likely market impact
Eligible IGL shareholders now receive EBL shares; key milestone in the demerger scheme advancing toward listing.